Literature DB >> 15319821

Regulation and function of inhibins in the normal menstrual cycle.

Corrine K Welt1.   

Abstract

The development of assays specific for dimeric inhibin A and inhibin B defined the distinct physiology of these two hormones in the normal menstrual cycle. Inhibin A and inhibin B expression and secretion along with their differential regulation by gonadotropins explain their unique serum patterns and their potential endocrine and ovarian autocrine-paracrine functions. There is evidence that inhibin A and inhibin B play an endocrine role in the negative regulation of follicle-stimulating hormone (FSH) in nonhuman primates and humans. However, some studies suggest that estradiol is a more important, if not the only, negative feedback regulator of FSH in women. There is also evidence from animal models that inhibins and activins play a critical role in follicle development. Future work will be necessary to define further the relative role of the inhibins, estradiol, and other autocrine-paracrine factors in these important reproductive functions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15319821     DOI: 10.1055/s-2004-831894

Source DB:  PubMed          Journal:  Semin Reprod Med        ISSN: 1526-4564            Impact factor:   1.303


  16 in total

1.  Neuroendocrine control of FSH secretion: IV. Hypothalamic control of pituitary FSH-regulatory proteins and their relationship to changes in FSH synthesis and secretion.

Authors:  Tejinder P Sharma; Terry M Nett; Fred J Karsch; David J Phillips; James S Lee; Carol Herkimer; Vasantha Padmanabhan
Journal:  Biol Reprod       Date:  2012-06-07       Impact factor: 4.285

Review 2.  Inhibin at 90: from discovery to clinical application, a historical review.

Authors:  Yogeshwar Makanji; Jie Zhu; Rama Mishra; Chris Holmquist; Winifred P S Wong; Neena B Schwartz; Kelly E Mayo; Teresa K Woodruff
Journal:  Endocr Rev       Date:  2014-07-22       Impact factor: 19.871

Review 3.  Activins and Inhibins: Roles in Development, Physiology, and Disease.

Authors:  Maria Namwanje; Chester W Brown
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-07-01       Impact factor: 10.005

4.  Updated assays for inhibin B and AMH provide evidence for regular episodic secretion of inhibin B but not AMH in the follicular phase of the normal menstrual cycle.

Authors:  John F Randolph; Siobán D Harlow; Margaret E Helmuth; Huiyong Zheng; Daniel S McConnell
Journal:  Hum Reprod       Date:  2013-12-18       Impact factor: 6.918

5.  Relating smoking, obesity, insulin resistance, and ovarian biomarker changes to the final menstrual period.

Authors:  MaryFran R Sowers; Daniel McConnell; Matheos Yosef; Mary L Jannausch; Sioban D Harlow; John F Randolph
Journal:  Ann N Y Acad Sci       Date:  2010-08       Impact factor: 5.691

Review 6.  Neuroendocrine, autocrine, and paracrine control of follicle-stimulating hormone secretion.

Authors:  Vasantha Padmanabhan; Rodolfo C Cardoso
Journal:  Mol Cell Endocrinol       Date:  2019-11-02       Impact factor: 4.102

7.  Estrogen negative feedback on gonadotropin secretion: evidence for a direct pituitary effect in women.

Authors:  N D Shaw; S N Histed; S S Srouji; J Yang; H Lee; J E Hall
Journal:  J Clin Endocrinol Metab       Date:  2010-02-04       Impact factor: 5.958

8.  Anti-Müllerian hormone and inhibin B variability during normal menstrual cycles.

Authors:  MaryFran Sowers; Daniel McConnell; Katherine Gast; Huiyong Zheng; Bin Nan; Jenifer D McCarthy; John F Randolph
Journal:  Fertil Steril       Date:  2009-12-06       Impact factor: 7.329

9.  Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition.

Authors:  MaryFran R Sowers; Aimee D Eyvazzadeh; Daniel McConnell; Matheos Yosef; Mary L Jannausch; Daowen Zhang; Sioban Harlow; John F Randolph
Journal:  J Clin Endocrinol Metab       Date:  2008-07-01       Impact factor: 5.958

10.  Growth differentiation factor 9 (GDF9) suppresses follistatin and follistatin-like 3 production in human granulosa-lutein cells.

Authors:  Feng-Tao Shi; Anthony P Cheung; He-Feng Huang; Peter C K Leung
Journal:  PLoS One       Date:  2011-08-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.